Telomerase Inhibition Targets Clonogenic Multiple Myeloma Cells through Telomere Length-Dependent and Independent Mechanisms
Sarah K. Brennan, Qiuju Wang, Robert Tressler et al. · 2010
Read Telomerase Inhibition Targets Clonogenic Multiple Myeloma Cells through Telomere Length-Dependent and Independent Mechanisms by Sarah K. Brennan, Qiuju Wang, Robert Tressler et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0012487.txt.
Description
Sarah Brennan, Qiuju Wang, Robert Tressler and colleagues blocked telomerase in multiple myeloma, in a 2010 PLOS ONE paper. Most myeloma tumor cells cannot sustain endless growth; a rarer clonogenic pool reseeds the cancer. Telomerase, the enzyme that maintains chromosome ends, keeps such stem-like cells going in many cancers and is a prized drug target.
Telomerase inhibition hit the clonogenic myeloma cells through both telomere shortening and a second, independent mechanism. Hitting the reseeding pool is what a lasting therapy must do, since killing only the bulk invites relapse. The dual mechanism strengthens the case for telomerase drugs in this blood cancer.
Catalog record
| CREATOR | Sarah K. Brennan, Qiuju Wang, Robert Tressler et al. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 38 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0012487